SCCM Resource Library-Epidemiology of Fungal Disease in the Critically Ill

Video Transcription

Video Summary

Dr. Talia Ben-Jacob from Cooper Hospital covered the epidemiology of fungal diseases in critically ill patients. Focusing on invasive candidiasis and aspergillosis, the talk highlighted their prevalence, patient risk factors, and clinical presentations. Invasive candidiasis, often diagnosed post-mortem, affects about 750,000 patients annually, with mortality rates up to 76.4% within a year. Aspergillosis affects approximately 300,000 patients yearly, seeing increased cases during the COVID-19 pandemic. New fungal infections, like Candida auris, have emerged, notable for their resistance and ease of transmission, with significant mortality rates. Explained were various risk factors including immunocompromised status and healthcare-associated causes, like antibiotics and medical procedures. Emphasized was the importance of surveillance cultures, antifungal stewardship, and meticulous infection control to mitigate resistance. Upcoming discussions will delve into innovative diagnostic and treatment methods for these challenging infections.

Asset Caption

One-Hour Concurrent Session | Deadly Fungus: Not the Last of Us Yet

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

fungal diseases

invasive candidiasis

aspergillosis

Candida auris

antifungal stewardship

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.